Comparison
Noopept vs CDP-Choline
Noopept
Russian-developed proline-containing dipeptide ~1000x more potent than piracetam by weight. Often grouped with racetams.
CDP-Choline
Cytidine 5'-diphosphocholine. Delivers both choline (for acetylcholine synthesis) and cytidine (for uridine and synaptic membrane synthesis), giving it a dual mechanism that distinguishes it from Alpha-GPC. The most-validated choline source for stroke recovery and age-related cognitive decline.
| Field | Noopept | CDP-Choline |
|---|---|---|
| Category | peptide | cholinergic |
| Dose range | 10–30mg | 250–500mg |
| Half-life | 0.5h | 56h |
| Onset | 20min | 60min |
| Evidence | EVIDENCEB | EVIDENCEA |
| Safety | ●●●●○ | ●●●●● |
| Legal (US) | USUnscheduled | USOTC |
| PubMed refs | 90 | 420 |
The comparison in plain English
Auto-generated from dataNoopept and CDP-Choline are both in the peptide (peptide) and cholinergic respectively. Noopept Russian-developed proline-containing dipeptide ~1000x more potent than piracetam by weight. CDP-Choline Cytidine 5'-diphosphocholine.
Bottom line
Noopept (evidence B, safety 4/5) has a stronger evidence base than CDP-Choline (evidence A, safety 5/5). CDP-Choline has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Noopept if
Noopept is the better fit when your goal aligns with its mechanism (Increases BDNF and NGF expression in the hippocampus and prefrontal cortex) and the dose range (10–30mg) suits your protocol. Half-life is 0.5h.
Choose CDP-Choline if
CDP-Choline is the better fit when your goal aligns with its mechanism (Hydrolysed into choline and cytidine in the gut) and the dose range (250–500mg) suits your protocol. Half-life is 56h.